Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Senate Appropriators Call For Botanical Identity Testing Guidance

This article was originally published in The Tan Sheet

Executive Summary

A Senate FDA appropriation report says the guidance would enhance the agency’s ability to inspect and assess industry practices for manufacturing botanical dietary supplements. A National Center for Natural Products Research official says most botanical ingredients lack standard identity tests.

Advertisement

Related Content

More GMP Warnings Likely As Botanicals Fail On Adulteration Awareness
More GMP Warnings Likely As Botanicals Fail On Adulteration Awareness
Congress Instructs FDA On Nanotech Work, But Mum On Regulations
Congress Instructs FDA On Nanotech Work, But Mum On Regulations
Congress Instructs FDA On Nanotech Work, But Mute On Funding
House, Senate Differ In Treating FDA China Syndrome
DMAA Warnings Shed Light On FDA NDI Enforcement
Consumers Challenge DMAA Safety After DOD Bans Products
Reps Threaten Legislation To Align NDI Guidance With DSHEA
Sanofi-Aventis offer

Topics

Advertisement
UsernamePublicRestriction

Register

PS105728

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel